Press Enter to search · ESC to close

Macro

Experts Say GLP-1 Weight-Loss Injections Not Confirmed to Cause Vision Loss

Experts said there is no confirmed causal link between GLP-1 weight-loss injections such as semaglutide and tirzepatide and vision damage or blindness, calling reported cases rare and isolated. The response came after social media users raised questions over whether the drugs can harm eyesight. The experts said occasional rare cases have been noted but a causal relationship has not been established.

Original source

AI take

The significance here lies less in the clinical finding than in the information dynamics: a social-media-driven scare is being met with a cautious, evidence-based response emphasizing that rare reported cases do not establish causation. This matters for the credibility of safety discourse around a drug class that has moved rapidly from clinical settings into mainstream use. The open question is whether the absence of a confirmed link will quiet the online concern or whether isolated cases keep resurfacing as anecdote outrunning evidence.

Generated by AI for reference only.

Share

Related News

TREE NEWS share card
Long-press image above → Save to Photos / Share
Pitch us Feedback